Australian climate-carbon cycle feedback reduced by soil black carbon

Annual emissions of carbon dioxide from soil organic carbon are an order of magnitude greater than all anthropogenic carbon dioxide emissions taken together1. Global warming is likely to increase the decomposition of soil organic carbon, and thus the release of carbon dioxide from soils2,3,4,5, creating a positive feedback6,7,8,9. Current models of global climate change that recognize this soil carbon feedback are inaccurate if a larger fraction of soil organic carbon than postulated has a very slow decomposition rate. Here we show that by including realistic stocks of black carbon in prediction models, carbon dioxide emissions are reduced by 18.3 and 24.4% in two Australian savannah regions in response to a warming of 3 ∘C over 100 years1. This reduction in temperature sensitivity, and thus the magnitude of the positive feedback, results from the long mean residence time of black carbon, which we estimate to be approximately 1,300 and 2,600 years, respectively. The inclusion of black carbon in climate models is likely to require spatially explicit information about its distribution, given that the black carbon content of soils ranged from 0 to 82% of soil organic carbon in a continental-scale analysis of Australia. We conclude that accurate information about the distribution of black carbon in soils is important for projections of future climate change

Testing a practical indicator for changing soil organic matter

Long-term changes in soil organic carbon (SOC) resulting from management change are documented for many experimental situations, and corresponding trends in the field have been observed by national survey. Since these changes are relevant to atmospheric carbon balance a practical measure to confirm the impact of recent management decisions at any location, without resorting to repeated sampling, is highly attractive but none has previously been tested. This study assessed intra-aggregate C to fulfil the role, based on a temporary deviation from its predictable contribution to total SOC under stable management. A total of 166 surface soil samples (0-15 cm) were analyzed for intra-aggregate C using an established physical fractionation protocol or compatible scaled-up procedure. Soils were arable (or ley-arable) managed by conventional or minimum-tillage, or permanent grassland, and assigned 'stable' or 'changing' status on the basis of a verbal account of management history. Log-normal populations of intra-aggregate C were compared for soils of stable and changing status using F-tests. Intra-aggregate C shows promise as an indicator of changing SOC in arable soils up to 30% clay content, particularly soils < 20% clay. A larger dataset is required to establish its utility in grassland soils. It is not certain that intra-aggregate C is capable of confirming direction of change or trajectory (endpoint), and functions to indicate change, rather than confirm stable status. Supplementary information on the history of soil use and management is therefore essential in the interpretation of such measurements

GPAQ-R: development and psychometric properties of a version of the general practice assessment questionnaire for use for revalidation by general practitioners in the UK.

BACKGROUND: The General Practice Assessment Questionnaire (GPAQ) has been widely used to assess patient experience in general practice in the UK since 2004. In 2013, new regulations were introduced by the General Medical Council (GMC) requiring UK doctors to undertake periodic revalidation, which includes assessment of patient experience for individual doctors. We describe the development of a new version of GPAQ - GPAQ-R which addresses the GMC's requirements for revalidation as well as additional NHS requirements for surveys that GPs may need to carry out in their own practices. METHODS: Questionnaires were given out by doctors or practice staff after routine consultations in line with the guidance given by the General Medical Council for surveys to be used for revalidation. Data analysis and practice reports were provided independently. RESULTS: Data were analysed for questionnaires from 7258 patients relating to 164 GPs in 29 general practices. Levels of missing data were generally low (typically 4.5-6%). The number of returned questionnaires required to achieve reliability of 0.7 were around 35 for individual doctor communication items and 29 for a composite score based on doctor communication items. This suggests that the responses to GPAQ-R had similar reliability to the GMC's own questionnaire and we recommend 30 completed GPAQ-R questionnaires are sufficient for revalidation purposes. However, where an initial screen raises concern, the survey might be repeated with 50 completed questionnaires in order to increase reliability. CONCLUSIONS: GPAQ-R is a development of a well-established patient experience questionnaire used in general practice in the UK since 2004. This new version can be recommended for use in order to meet the UK General Medical Council's requirements for surveys to be used in revalidation of doctors. It also meets the needs of GPs to ask about patient experience relating to aspects of practice care that are not specific to individual general practitioners (e.g. receptionists, telephone access) which meet other survey requirements of the National Health Service in England. Use of GPAQ-R has the potential to reduce the number of surveys that GPs need to carry out in their practices to meet the various regulatory requirements which they face

Pyrolysis final temperature effects on biochar stability.

Pyrolysis technology can be used for producing biochar and bio-oil simultaneously, as an effective and sustainable mean to produce renewable bioenergy and a carbon rich soil amendment that can be used for carbon sequestration and agronomic benefits. However, pyrolysis products yields and biochar stability are strongly affected by the feedstock and pyrolysis variables, especially the final temperature. This study was carried out to evaluate the effect of pyrolysis final temperature on biochar stability after thermochemical oxidation. For this experiment, two species of hardwood and two species of softwood with particle size between 0.5 and 2.0 mm were pyrolized at five different final temperatures (350, 400, 450, 500 and 550°C) for 60 min at an muffle furnace with limited supply of O2. Thermochemical oxidation was performed for the solid products (biochar). As pyrolysis final temperature increased, biochar stability increased as well, indicating that these materials would be more resistant to degradation when applied into soil

Trends in the recovery of phosphorus in bioavailable forms from wastewater

Addressing food security issues arising from phosphorus (P) scarcity is described as one of the greatest global challenges of the 21st Century. Dependence on inorganic phosphate fertilisers derived from limited geological sources of P creates an urgent need to recover P from wastes and treated waters, in safe forms that are also effective agriculturally – the established process of P removal by chemical precipitation using Fe or Al salts, is effective for P removal but leads to residues with limited bioavailability and contamination concerns. One of the greatest opportunities for P recovery is at wastewater treatment plants (WWTPs) where the crystallisation of struvite and Ca-P from enhanced biological P removal (EBPR) sludge is well developed and already shown to be economically and operationally feasible in some WWTPs. However, recovery through this approach can be limited to &lt;25% efficiency unless chemical extraction is applied. Thermochemical treatment of sludge ash produces detoxified residues that are currently utilised by the fertiliser industry; wet chemical extraction can be economically feasible in recovering P and other by-products. The bioavailability of recovered P depends on soil pH as well as the P-rich material in question. Struvite is a superior recovered P product in terms of plant availability, while use of Ca-P and thermochemically treated sewage sludge ash is limited to acidic soils. These technologies, in addition to others less developed, will be commercially pushed forward by revised fertiliser legislation and foreseeable legislative limits for WWTPs to achieve discharges of &lt;1 mg P/L

Effects of Protein Deficiency on Perinatal and Postnatal Health Outcomes

There are a variety of environmental insults that can occur during pregnancy which cause low birth weight and poor fetal health outcomes. One such insult is maternal malnutrition, which can be further narrowed down to a low protein diet during gestation. Studies show that perinatal protein deficiencies can impair proper organ growth and development, leading to long-term metabolic dysfunction. Understanding the molecular mechanisms that underlie how this deficiency leads to adverse developmental outcomes is essential for establishing better therapeuticstrategies that may alleviate or prevent diseases in later life. This chapter reviews how perinatal protein restriction in humans and animals leads to metabolic disease, and it identifies the mechanisms that have been elucidated, to date. These include alterations in transcriptional and epigenetic mechanisms, as well as indirect means such as endoplasmic reticulum (ER) stress and oxidative stress. Furthermore, nutritional and pharmaceutical interventions are highlighted to illustrate that the plasticity of the underdeveloped organs during perinatal life can be exploited to prevent onset of long-term metabolic disease

Maternal Undernutrition and Long-term Effects on Hepatic Function

Undernutrition in utero, regardless of the source, can impair proper liver development leading to long-term metabolic dysfunction. Understanding the molecular mechanisms underlying how nutritional deficits during perinatal life lead to permanent alterations in hepatic gene expression will provide better therapeutic strategies to alleviate the undernourished liver in postnatal life. This chapter addresses the different experimental models of undernutrition in utero, and highlights the direct and indirect mechanisms involved leading to metabolic diseases in the liver. These include hypoxia, oxidative stress, epigenetic alterations, and endoplasmic reticulum (ER) stress. In addition, promising perinatal nutritional and pharmaceutical interventions are highlighted which illustrate how the placidity of the developing liver can be exploited to prevent the onset of long-term metabolic disease